{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:15:03Z","timestamp":1791216903044,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.1093\/alcalc\/agh130","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T01:34:30Z","timestamp":1102988070000},"page":"147-150","source":"Crossref","is-referenced-by-count":195,"title":["COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN"],"prefix":"10.1093","volume":"40","author":[{"given":"OLIVIER","family":"AMEISEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,12,13]]},"reference":[{"key":"key\n\t\t\t\t20171010165412_B1","unstructured":"Addolorato, G., Caputo, F., Capristo, E. et al. (2000) Ability of baclofen in reducing alcohol craving and intake: II \u2014 a preliminary clinical evidence. Alcoholism: Clinical and Experimental Research24, 67\u201371."},{"key":"key\n\t\t\t\t20171010165412_B2","doi-asserted-by":"crossref","unstructured":"Addolorato, G., Caputo, F., Capristo, E. et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol and Alcoholism37, 504\u2013508.","DOI":"10.1093\/alcalc\/37.5.504"},{"key":"key\n\t\t\t\t20171010165412_B3","doi-asserted-by":"crossref","unstructured":"Addolorato, G., Caputo, F., Capristo, E. et al. (2002) Rapid suppression of alcohol withdrawal syndrome by baclofen. American Journal of Medicine112, 226\u2013229.","DOI":"10.1016\/S0002-9343(01)01088-9"},{"key":"key\n\t\t\t\t20171010165412_B4","unstructured":"American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. APA, Washington, DC."},{"key":"key\n\t\t\t\t20171010165412_B5","doi-asserted-by":"crossref","unstructured":"Brambilla, P., Perez, J., Barale, F. et al. (2003) GABAergic dysfunction in mood disorders. Molecular Psychiatry8, 715, 721\u2013737.","DOI":"10.1038\/sj.mp.4001395"},{"key":"key\n\t\t\t\t20171010165412_B6","doi-asserted-by":"crossref","unstructured":"Brebner, K., Ahn, S. and Phillips, A. G. (2004) Attenuation of D-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl) Jul 22 [Epub ahead of print].","DOI":"10.1007\/s00213-004-1968-6"},{"key":"key\n\t\t\t\t20171010165412_B7","doi-asserted-by":"crossref","unstructured":"Breslow, M. F., Fankhauser, M. P., Potter, R. L. et al. (1989) Role of gamma-aminobutyric acid in antipanic drug efficacy. American Journal of Psychiatry146, 353\u2013356.","DOI":"10.1176\/ajp.146.3.353"},{"key":"key\n\t\t\t\t20171010165412_B8","unstructured":"Colombo, G., Agabio, R., Carai, M. A. et al. (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity: I. Preclinical evidence. Alcoholism: Clinical and Experimental Research24, 58\u201366."},{"key":"key\n\t\t\t\t20171010165412_B9","doi-asserted-by":"crossref","unstructured":"Colombo, G., Vacca, G., Serra, S. et al. (2003) Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl)167, 221\u2013224 [Epub April 1, 2003].","DOI":"10.1007\/s00213-003-1397-y"},{"key":"key\n\t\t\t\t20171010165412_B10","doi-asserted-by":"crossref","unstructured":"Davidoff, R. A. (1985) Antispasticity drugs: mechanisms of action. Annals of Neurology17, 107\u2013116.","DOI":"10.1002\/ana.410170202"},{"key":"key\n\t\t\t\t20171010165412_B11","doi-asserted-by":"crossref","unstructured":"Deroche-Gamonet, V., Belin, D. and Piazza, P. V. (2004) Evidence for addiction-like behavior in the rat. Science305, 1014\u20131017.","DOI":"10.1126\/science.1099020"},{"key":"key\n\t\t\t\t20171010165412_B12","doi-asserted-by":"crossref","unstructured":"Drake, R. G., Davis, L. L., Cates, M. E. et al. (2003) Baclofen treatment for chronic posttraumatic stress disorder. The Annals of Pharmacotherapy37, 1177\u20131181.","DOI":"10.1345\/aph.1C465"},{"key":"key\n\t\t\t\t20171010165412_B13","doi-asserted-by":"crossref","unstructured":"Fattore, L., Cossu, G., Martellotta, M. C. et al. (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol and Alcoholism37, 495\u2013498.","DOI":"10.1093\/alcalc\/37.5.495"},{"key":"key\n\t\t\t\t20171010165412_B14","doi-asserted-by":"crossref","unstructured":"Froehlich, J., O'Malley, S., Hyytia, P. et al. (2003) Preclinical and clinical studies on naltrexone: what have they taught each other? Alcoholism: Clinical and Experimental Research27, 533\u2013539.","DOI":"10.1097\/01.ALC.0000057943.57330.AB"},{"key":"key\n\t\t\t\t20171010165412_B15","doi-asserted-by":"crossref","unstructured":"Gerkin, R., Curry, S. C., Vance, M. V. et al. (1986) First-order elimination kinetics following baclofen overdose. Annals of Emergency Medicine15, 843\u2013846.","DOI":"10.1016\/S0196-0644(86)80388-2"},{"key":"key\n\t\t\t\t20171010165412_B16","doi-asserted-by":"crossref","unstructured":"Grant, B. F., Stinson, F. S., Dawson, D. A. et al. (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry61, 807\u2013816.","DOI":"10.1001\/archpsyc.61.8.807"},{"key":"key\n\t\t\t\t20171010165412_B17","doi-asserted-by":"crossref","unstructured":"Johnson, B. A., Ait-Daoud, N., Bowden, C. L. et al. (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet361, 1677\u20131685.","DOI":"10.1016\/S0140-6736(03)13370-3"},{"key":"key\n\t\t\t\t20171010165412_B18","doi-asserted-by":"crossref","unstructured":"Johnson, B. A., Ait-Daoud, N., Akhtar, F. Z. et al. (2004) Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Archives of General Psychiatry61, 905\u2013912.","DOI":"10.1001\/archpsyc.61.9.905"},{"key":"key\n\t\t\t\t20171010165412_B19","doi-asserted-by":"crossref","unstructured":"Kampman, K. M., Pettinati, H., Lynch, K. G. et al. (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug and Alcohol Dependence75, 233\u2013240.","DOI":"10.1016\/j.drugalcdep.2004.03.008"},{"key":"key\n\t\t\t\t20171010165412_B20","doi-asserted-by":"crossref","unstructured":"Kranzler, H. R., Wesson, D. R., Billot, L. et al. (2004) Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcoholism: Clinical and Experimental Research28, 1051\u20131059.","DOI":"10.1097\/01.ALC.0000130804.08397.29"},{"key":"key\n\t\t\t\t20171010165412_B21","doi-asserted-by":"crossref","unstructured":"Krupitsky, E. M., Burakov, A. M., Ivanov, V. B. et al. (1993) Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug and Alcohol Dependence33, 157\u2013163.","DOI":"10.1016\/0376-8716(93)90057-W"},{"key":"key\n\t\t\t\t20171010165412_B22","doi-asserted-by":"crossref","unstructured":"Morse, R. M. and Flavin, D. K. (1992) The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism. The Journal of the American Medical Association268, 1012\u20131014.","DOI":"10.1001\/jama.1992.03490080086030"},{"key":"key\n\t\t\t\t20171010165412_B23","unstructured":"Nemeroff, C. B. (2003) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacological Bulletin37, 133\u2013146."},{"key":"key\n\t\t\t\t20171010165412_B24","doi-asserted-by":"crossref","unstructured":"Nielsen, J. F., Hansen, H. J., Sunde, N. et al. (2002) Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clinical Neurology and Neurosurgery104, 142\u2013145.","DOI":"10.1016\/S0303-8467(02)00009-4"},{"key":"key\n\t\t\t\t20171010165412_B25","doi-asserted-by":"crossref","unstructured":"Pelc, I., Ansoms, C., Lehert, P. et al. (2002) The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcoholism: Clinical and Experimental Research26, 1529\u20131538.","DOI":"10.1111\/j.1530-0277.2002.tb02452.x"},{"key":"key\n\t\t\t\t20171010165412_B26","doi-asserted-by":"crossref","unstructured":"Roberts, D. C. and Andrews, M. M. (1997) Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology (Berl)131, 271\u2013277.","DOI":"10.1007\/s002130050293"},{"key":"key\n\t\t\t\t20171010165412_B27","unstructured":"Shoaib, M., Swanner, L. S., Beyer, C. E. et al. (1998) The GABAB agonist baclofen modifies cocaine self-administration in rats. Behavioral Pharmacology9, 195\u2013206."},{"key":"key\n\t\t\t\t20171010165412_B28","doi-asserted-by":"crossref","unstructured":"Shoptaw, S., Yang, X., Rotheram-Fuller, E. J. et al. (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. The Journal of Clinical Psychiatry64, 1440\u20131448.","DOI":"10.4088\/JCP.v64n1207"},{"key":"key\n\t\t\t\t20171010165412_B29","doi-asserted-by":"crossref","unstructured":"Smith, C. R., LaRocca, N. G., Giesser, B. S. et al. (1991) High-dose oral baclofen: experience in patients with multiple sclerosis. Neurology41, 1829\u20131831.","DOI":"10.1212\/WNL.41.11.1829"},{"key":"key\n\t\t\t\t20171010165412_B30","unstructured":"Xi, Z. X. and Stein, E. A. (1999) Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. The Journal of Pharmacology and Experimental Therapeutics290, 1369\u20131374."}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/alcalc\/article-pdf\/40\/2\/147\/347942\/agh130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T17:59:08Z","timestamp":1586023148000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/alcalc\/article\/40\/2\/147\/148774\/COMPLETE-AND-PROLONGED-SUPPRESSION-OF-SYMPTOMS-AND"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,13]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,12,13]]},"published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agh130","relation":{},"ISSN":["1464-3502","0735-0414"],"issn-type":[{"value":"1464-3502","type":"electronic"},{"value":"0735-0414","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,3]]},"published":{"date-parts":[[2004,12,13]]}}}